Why the study?
Do renin-angiotensin-aldosterone system gene polymorphisms predict improvement in left ventricular ejection fraction following medical therapy in patients with idiopathic dilated cardiomyopathy?
Do renin-angiotensin-aldosterone system gene polymorphisms predict improvement in left ventricular ejection fraction following medical therapy in patients with idiopathic dilated cardiomyopathy?
The CYP11B2 (aldosterone synthase) gene variant predicts LVEF improvement in patients with idiopathic dilated cardiomyopathy receiving standard medical therapy, suggesting a genetic role in heart failure progression.
No takes yet. Share an insight, caveat, or question.
CYP11B2 variant may identify LVEF responders to medical therapy in idiopathic dilated cardiomyopathy; hypothesis-generating and requires prospective validation before clinical use.
Tiago et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: